#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4804765	B	Inhibition of human AAK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
2.	ALA4804766	B	Inhibition of phosphorylated human ABL1 E255K mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
3.	ALA4804767	B	Inhibition of non-phosphorylated human ABL1 F317I mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
4.	ALA4804768	B	Inhibition of phosphorylated human ABL1 F317I mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
5.	ALA4804769	B	Inhibition of non-phosphorylated human ABL1 F317L mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
6.	ALA4804770	B	Inhibition of phosphorylated human ABL1 F317L mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
7.	ALA4804771	B	Inhibition of non-phosphorylated human ABL1 H369P mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
8.	ALA4804772	B	Inhibition of phosphorylated human ABL1 H369P mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
9.	ALA4804773	B	Inhibition of phosphorylated human ABL1 M351T mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
10.	ALA4804774	B	Inhibition of phosphorylated human ABL1 Q252H mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
11.	ALA4804775	B	Inhibition of non-phosphorylated human ABL1 Q252H mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
12.	ALA4804776	B	Inhibition of phosphorylated human ABL1 T315I mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
13.	ALA4804777	B	Inhibition of non-phosphorylated human ABL1 T315I mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
14.	ALA4804778	B	Inhibition of phosphorylated human ABL1 Y253F mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
15.	ALA4804779	B	Inhibition of non-phosphorylated human ABL1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
16.	ALA4804780	B	Inhibition of phosphorylated human ABL1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
17.	ALA4804781	B	Inhibition of human ABL2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
18.	ALA4804782	B	Inhibition of human ACVR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
19.	ALA4804783	B	Inhibition of human ACVR1B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data
20.	ALA4804784	B	Inhibition of human ACVR2A assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	Homo sapiens	1		single protein format	Patent Bioactivity Data